(R)-methyl 4-(N-((6-cyclohexylpyridin-3-yl)methyl)-1-(perfluorophenylsulfonyl)azetidine-2-carboxamido)-2-hydroxybenzoate

ID: ALA4763364

PubChem CID: 151798262

Max Phase: Preclinical

Molecular Formula: C30H28F5N3O6S

Molecular Weight: 653.63

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1ccc(N(Cc2ccc(C3CCCCC3)nc2)C(=O)[C@H]2CCN2S(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1O

Standard InChI:  InChI=1S/C30H28F5N3O6S/c1-44-30(41)19-9-8-18(13-22(19)39)37(15-16-7-10-20(36-14-16)17-5-3-2-4-6-17)29(40)21-11-12-38(21)45(42,43)28-26(34)24(32)23(31)25(33)27(28)35/h7-10,13-14,17,21,39H,2-6,11-12,15H2,1H3/t21-/m1/s1

Standard InChI Key:  RYBCPRABHVSVDN-OAQYLSRUSA-N

Molfile:  

 
     RDKit          2D

 45 49  0  0  0  0  0  0  0  0999 V2000
   23.6201  -17.6645    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.2021  -18.2465    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   24.4151  -17.4515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.8112  -18.8284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8112  -19.6456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6284  -19.6456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6284  -18.8284    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.9955  -18.4620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2034  -19.2525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9919  -19.4641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5707  -18.8860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3556  -18.0932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5674  -17.8853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2333  -18.2505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4448  -17.4612    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.4440  -18.4620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.3528  -17.0968    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   24.6241  -19.8289    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.9314  -17.5134    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   27.3603  -19.0964    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.2030  -20.2536    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.8661  -17.8842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0768  -18.0957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5029  -17.5152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7142  -17.7261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5020  -18.5162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0847  -19.0952    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8712  -18.8812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2325  -19.2514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4428  -19.4581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2311  -20.2466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8093  -20.8254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6020  -20.6102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8100  -19.8221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6002  -21.6171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8111  -21.8296    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1788  -22.1941    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7116  -18.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1339  -18.1476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3464  -18.3577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1315  -19.1479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7104  -19.7280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5042  -19.5179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1819  -21.1860    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.2325  -21.2525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  4  1  0
  7  2  1  0
  2  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  4 14  1  6
 14 15  2  0
 14 16  1  0
 13 17  1  0
  9 18  1  0
 12 19  1  0
 11 20  1  0
 10 21  1  0
 16 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 16 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 35 36  1  0
 35 37  2  0
 32 35  1  0
 26 38  1  0
 38 39  1  0
 38 43  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 33 44  1  0
 36 45  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4763364

    ---

Associated Targets(Human)

MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Stat3 Signal transducer and activator of transcription 3 (376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 653.63Molecular Weight (Monoisotopic): 653.1619AlogP: 5.31#Rotatable Bonds: 8
Polar Surface Area: 117.11Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.37CX Basic pKa: 5.07CX LogP: 5.72CX LogD: 5.71
Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.15Np Likeness Score: -1.02

References

1. Brotherton-Pleiss C,Yue P,Zhu Y,Nakamura K,Chen W,Fu W,Kubota C,Chen J,Alonso-Valenteen F,Mikhael S,Medina-Kauwe L,Tius MA,Lopez-Tapia F,Turkson J.  (2021)  Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors.,  64  (1.0): [PMID:33352047] [10.1021/acs.jmedchem.0c01705]

Source